11-beta-hydroxylase deficiency

Not yet reviewed

This information is AI generated and has not yet been reviewed by a specialist physician. AI can make mistakes.

Disease overview

Autosomal recessive disorder caused by mutation in CYP11B1 gene causing adrenal glands to produce excess androgens.

Common symptoms

Urogenital Defects (Urogenital Defects: Long PenisAmbiguous genitaliaClitoral hypertrophyIrregular menstruation) and Musculoskeletal Defects (Musculoskeletal Defects: Short statureAccelerated skeletal maturationGrowth abnormality)

When to suspect

  • Recommendation 1

    Physical Exam Findings in Girls (Diagnosis of girls with classic CAH due to 11-beta-hydroxylase deficiency (11beta-OHD) is usually at birth when virilization of external genitalia is present) and pre-birth genetic testing (Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member or in case of genital abnormalties diagnosed antenatally in girls)

How to test

  • Recommendation 1

    Physical Exam Findings in Girls (Diagnosis of girls with classic CAH due to 11-beta-hydroxylase deficiency (11beta-OHD) is usually at birth when virilization of external genitalia is present) and pre-birth genetic testing (Prenatal diagnosis is possible where the pathogenic variant has previously been identified in a family member or in case of genital abnormalties diagnosed antenatally in girls)

ZebraMD is partnering with Ambry Genetics for clinical-grade whole genome testing for rare diseases. Ambry accepts insurance. If you don’t have a physician to order this test, join our referral list and our team will reach out.

Treatment

  • Recommendation 1

    Dexamethasone adminstered prenatally and GC replacement therapy throughout life

Primary care

  • Recommendation 1

    Surgery for genital defects and GC (hydrocortizone) therapy throughout lifetime

Further support

Clinical trials

Clinical Trials

Sources

No data available

Interested in learning more about 11-beta-hydroxylase deficiency?

Follow to receive regular updates to the latest research development on this disease via email newsletter.